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INTRODUCTION
Portal hypertension is the most common 
complication of cirrhosis accounting for signif-
icant morbidity and mortality mainly because 
of variceal hemorrhage, ascites, bacterial infec-
tions, hepatic encephalopathy and hepatorenal 
syndrome. In patients with cirrhosis the over-
all incidence of variceal bleeding is about 4% 
to 15% per year. Fatal outcome is above 30% in 
the first episode of bleeding. Patients surviving 
the first episode of variceal bleeding have a risk 
of over 60% of experiencing recurrent haemor-
rhage within two years from the index episode. 
Because of this, all patients surviving variceal 
bleeding should receive active treatment for the 
prevention of rebleeding. Available treatments 
for preventing variceal rebleeding include 
pharmacological therapy, endoscopic therapy, 
transjugular intrahepatic portosystemic shunt 
(TIPS) and surgical shunting [1, 2, 3].
Endoscopic treatment is a local treatment 
aimed at eradicating the varices. Since it does 
not decrease portal pressure, the varices may 
recur after endoscopic treatment, and patients 
need to receive a life-long endoscopic follow-
up to detect variceal recurrence. Endoscopic 
band ligation (EBL) is clearly superior to endo-
scopic injection sclerotherapy (EIS) due to less 
frequent and severe complications, but EBL is 
associated with a higher rate of variceal recur-
rence [4, 5, 6].
The data in the literature about effects of 
sclerotherapy performed on remnant little 
varices after endoscopic ligation on reducing 
of recurrent varices are scarce.
OBJECTIVE
The aim of this study was to examine whether 
recurrent varices reduction can be achieved by 
additional sclerotherapy of remnant little vari-
ces after ligation.
METHODS
Forty-eight patients with liver cirrhosis who 
previously bled from oesophageal varices were 
examined. Endoscopic therapy was performed 
in order to prevent recurrent variceal bleed-
ing. All patients gave their consent before endo-
scopic treatment was undertaken.
I group: in 23 patients the ligation of oesoph-
ageal varices with a multi band ligation device 
was applied (EBL group). II group: in 25 
patients sclerotherapy was applied after reduc-
ing the size of varices using ligation (EBL and 
EIS group). The examined groups of patients 
did not differ significantly according to gender, 
age, cause of cirrhosis, varices size and Child-
Pugh’s class (Table 1). All examined patients 
had portal gastropathy. The exclusion criteria 
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were: 1) association with gastric varices; 2) association with 
malignancy, uraemia, or other debilitating diseases; and 3) 
history of sclerotherapy or shunt operation. Beta-blockers 
were not administered during the study.
Endoscopy was carried out under topical oropharyngeal 
anaesthesia. Conscious sedation was provided with intra-
venous midasolam only in agitated patients.
In the EBL group of patients banding started at the 
gastroesophageal junction, and then continued proximally 
for several centimetres. The treatment was repeated at two-
week intervals until the varices completely disappeared or 
were significantly reduced to small residual varices gr I 
(Figures 1-4). In the EBL and EIS group of patients banding 
was also started at the gastroesophageal junction. The treat-
ment was repeated at two-week intervals until the varices 
were significantly reduced to small residual varices grade 
I. After that, one session of sclerotherapy using polydo-
canol or absolute alcohol of 0.5 ml per injection until the 
total quantity of 10 ml, was applied. The sites of injections 
were confined to the distal oesophagus and intended for 
intravariceal injection.
Thereafter, in both groups of patients follow-up endo-
scopic examination was applied every three months to 
detect recurrence of oesophageal varices, deterioration of 
portal gastropathy or occurrence of gastric varices. Portal 
hypertensive gastropathy was assessed as macroscopic find-
ing of a characteristic mosaic-like pattern of the gastric 
mucosa (mild portal hypertensive gastropathy), red-point 
lesions, cherry red spots, and/or black-brown spots (severe 
portal hypertensive gastropathy) [1, 7]. For patients with 
recurrent oesophageal varices, a repeated session of EBL 
was performed in both groups of patients. When rebleeding 
from the oesophageal varices was encountered, repeated 
sessions of EBL were performed in both groups until the 
varices were obliterated.
The descriptive statistical methods used included 
measures of central tendency (mean value – X) and a 
measure of dispersion (standard deviation – SD). The 
methods of statistical analysis used to asses the significance 
of differences included Student’s t test, Mantel-Haenszel’s 
χ2 test with Yates corrections and Fisher’s exact test. The 
level of significance was p<0.05.
Table 1. Characteristics of examined groups of patients
Parameter EBL group EBL and EIS 
group
Number of patients (male/female) 23 (19/4) 25 (21/4)
Age (years), mean ± SD (min-max) 56.2±8.02 
(43-71)
57.6±8.05 
(41-75)
Alcoholic cirrhosis (n) 13 (56.5%) 13 (52%)
Postviral cirrhosis (n) 6 (26%) 6 (24%)
Alcoholic and postviral cirrhosis (n) 4 (17.3%) 6 (24%)
Varices grade II (n) 7 (30.4%) 8 (32%)
Varices grade III (n) 12 (52.1%) 13 (52%)
Varices grade IV (n) 4 (17.3%) 4 (16%)
Child–Pugh A (n) 11 (47.8%) 13 (52%)
Child–Pugh B (n) 10 (43.4%) 10 (40%)
Child–Pugh C (n) 2 (8.6%) 2 (8%)
p>0.05; n – number of patients
Figure 1. Approximation of the endoscope tip mounted with the multi-
band ligator until there is full contact with the varix
Figure 2. Suction of the oesophageal mucosa, submucosa, and the varix
Figure 3. Strangulation of the varix with the rubber band
Figure 4. Three ligated varices at the bottom of the oesophagus
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of sessions for variceal eradication (3.85±1.06 in the EBL 
group vs. 2.93±1.07 in the EBL and EIS group).
Variceal recurrence was verified more frequently in 
the EBL group of patients (21.7%) than in the EBL and 
EIS group (16%), in the observed period from 18.8±18.6 
months (EBL group) and 22.2±26.2 months (EBL and EIS 
group), but the difference was not statistically important 
(p>0.05).
Recurrence of variceal bleeding was verified only in one 
patient (4.3%) in the EBL group and also in one patient 
(4%) in the EBL and EIS group in the observed periods.
Deterioration of portal gastropathy occurred in two 
patients (8.6%) of the EBL group and in six patients (24%) 
of the EBL and EIS group, but the difference was not statis-
tically important (p>0.05).
Gastric varices did not occur in any patient of the EBL 
groups and of the EBL and EIS group in the observed peri-
ods.
The same number of patients died in both of the exam-
ined groups. Mortality was related to the deterioration of 
liver function, but not to variceal bleeding (Table 2).
All complications in both groups of patients were not 
life depriving, but some, such as dysphagia and chest pain, 
were statistically more frequent in the EBL and EIS group 
of patients (44% vs. 13% respectively for dysphagia, and 
40% vs. 8.6% respectively for chest pain). Fever was verified 
in one patient (4.3%) in the EBL group and three patients 
(12%) in the EBL and EIS group, but the difference was 
not statistically important. Oesophageal ulcer was verified 
only in the EBL and EIS group in two patients (8%) (Table 
3). All complications in the EBL and EIS group of patients 
occurred after final session of sclerotherapy of remnant 
little varices after ligation.
DISCUSSION
Despite the fact that much progress has been made in 
treatment and research over the recent decades, variceal 
hemorrhage is still one of the most severe complications 
of liver cirrhosis. All patients who survive an episode of 
acute variceal bleeding should undergo secondary prophy-
laxis. A number of trials have demonstrated that EBL is 
superior to EIS with regard to the time required to achieve 
variceal eradication, the rate of recurrent bleeding and 
treatment induced complications. Thus, EBL is at pres-
ent the endoscopic treatment of choice. However, EBL 
is associated with a higher rate of recurrence of varices, 
because the obliteration of paraesophageal varices is not 
possible [8, 9, 10].
The effort to identify an optimal endoscopic technique 
for variceal eradication led to the combination of EBL and 
EIS. In combined endoscopic therapy sclerotherapy has 
been added to EBL either simultaneously or after the reduc-
tion of variceal size to small. Meta-analysis of the simulta-
neously performed EBL and EIS did not show any benefit 
to EBL alone, either for rebleeding or for mortality, and it 
also showed a trend towards an increasing complication 
rate with combined endoscopic therapy. Therefore, there 
is no rationale to combine both endoscopic approaches 
simultaneously [11, 12, 13].
Few studies in the literature suggest that performing of a 
small amount of sclerosing agent on the varices after their 
reduction in size with EBL, result in less frequent variceal 
recurrence and rebleeding rate. Sclerotherapy of these little 
remnant varices after ligation is technically more accessible 
than ligation alone, because it is more difficult to achieve 
their aspiration by ligation. Also, it is possible that sclero-
therapy may obliterate paraesophageal varices and achieve 
decrease of variceal reccurence. Thus, EIS can be useful 
in very small remanent varices after ligation [14, 15, 16]. 
There were also a small number of variceal recurrences 
in our group treated by the combination of ligation and 
sclerotherapy (16%) in relation to the group treated only 
by ligation (21.7%), but the difference was not statistically 
important. Rebleeding was verified in the same percent-
age in both groups of our patients. It should be kept in 
mind that the limiting factor in our study was the sample 
size, which probably prevented adequate statistical results.
After sclerotherapy, a higher number of patients develop 
portal gastropathy than after ligation, while the occur-
rence of gastric varices is similar. The reason for this is 
that deeper ulcers occur after sclerotherapy resulting in 
the development of fibrous tissue and that there is obliter-
ation of perforated oesophageal veins, and thus an increase 
of portal pressure and redistribution in the portal vascular 
system [17, 18, 19]. These changes caused by sclerotherapy 
should be less frequent in a combined method of ligation 
and sclerotherapy of varices, because of the application of 
a small amount of sclerosing agent. Nevertheless, in our 
patients the deterioration of portal gastropathy was veri-
fied more often in the group of patients treated by ligation 
and additional sclerotherapy of varices (24%) in relation 
to the group of patients treated only by ligation of vari-
ces (8.6%), but the difference was not statistically impor-
tant. In both groups of treated patients we did not verify 
the appearance of gastric varices in the observed periods.
The complications after the ligation of varices are rare 
and milder than after scleroptherapy. Chest pain and 
dysphagia are transitory. The complications of endoscopic 
Table 3. Complications
Complication EBL group EBL and EIS 
group p
Dysphagia 3 (13%) 11 (44%) <0.05
Chest pain 2 (8.6%) 10 (40%) <0.05
Fever 1 (4.3%) 3 (12%) >0.05
Oesophageal ulcer 0 2 (8%) >0.05
Table 2. Treatment results in the compared groups
Parameter EBL group EBL and EIS 
group
Treatment sessions to eradicate 
varices 3.85±1.06 2.93±1.07
Variceal recurrence (n) 5 (21.7%) 4 (16%)
Variceal rebleeding (n) 1 (4.3%) 1 (4%)
Deterioration of portal gastropathy (n) 2 (8.6%) 6 (24%)
Mortality (n) 3 (13%) 3 (12%)
Follow-up (months) 18.8±18.6 22.2±26.2
p>0.05; n – number of patients331
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sclerotherapy are numerous: dysphagia, chest pain, febril-
ity, small pleural effusions, ulcers and oesophageal steno-
ses. The most serious side effects of sclerotherapy are 
dysphagia, oesophageal stenosis and bleeding of oesoph-
ageal ulcers, which may account for as much as 14% of all 
rebleeding episodes [1]. We should expect fewer compli-
cations with the application of the combined method of 
ligation and additional variceal sclerotherapy for apply-
ing small amounts of sclerosing agents, which was shown 
by researches Lo et al. [14]. Nevertheless, in this study 
some complications, such as dysphagia and chest pain, were 
statistically more frequent after session of sclerotherapy in 
the group of patients on combined endoscopic therapy.
Some studies examined the effect of variceal ligation 
followed by mucosa-fibrosing with microwave on vari-
ceal recurrence. Recurrence of varices occurred in 60% 
of patients treated only by ligation and in 16% of patients 
treated by combined therapy (p=0.03) [20]. Similar results 
were achieved with argon plasma coagulation after ligation 
[21, 22, 23]. A recent study by Monici et al. [24] showed 
that application of microwave coagulation to oesopha-
geal varices after band ligation was safe. The post micro-
wave coagulation recurrence rate may be comparable to 
that observed following the combined treatment of EBL 
and EIS. The presence of gastric varices increases the risk 
of oesophageal variceal recurrence. However, long-term 
effects of different combined endoscopic methods on the 
reduction of variceal recurrence after ligation is not clear 
enough for now.
CONCLUSION
In conclusion, the combined method of ligation and extra 
sclerosing of remnant small varices after ligation does not 
have advantages compared to the ligation alone, but more 
extensive studies are required.
NOTE
The paper was presented at the 11th European Bridging 
Meeting in Gastroenterology in Belgrade, Serbia, on 31st 
October and 1st November 2009.
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КРА ТАК  СА ДР ЖАЈ
Увод  Е н  д о  с к о п  с к о   б а н д - л и  г и  р а  њ е   ( Е Б Л )   в а  р и к  с а   ј е д  њ а  к а  
је  мно го  бо ље  од  ен до скоп ске  инјекци о не  скле ро те ра пи је 
(ЕИС), али је ре  ци  див ва  рик  са ве  ћи на  кон ЕБЛ.
Циљ ра  да Циљ ра  да је био да се ис  пи  та мо  же ли се по  сти-
ћ и  с м а  њ е  њ е  р е  ц и  д и  в а  в а  р и к  с а  д о  д а т  н о м  с к л е  р о  т е  р а  п и  ј о м  
за о ста лих  ма лих  ва рик са  на кон  ли ги ра ња.
М е  т о  д е  р а  д а  У ис  пи  ти  ва  ње је укљу  че  но 48 осо  ба са ци  ро-
зом је тре код ко јих су уста но вље на прет ход на кр ва ре ња из 
в а  р и к  с а  ј е д  њ а  к а .  Е н  д о  с к о п  с к а  т е  р а  п и  ј а  ј е  п р и  м е  њ е  н а  р а  д и  
п р е  в е н  ц и  ј е  р е  ц и  д и  в а  к р  в а  р е  њ а .  И с  п и  т а  н и  ц и  с у  с в р  с т а  н и  у  
две гру  пе: пр  ву су чи  ни  ла 23 бо  ле  сни  ка код ко  јих је при  ме-
њ е  н о  л и  г и  р а  њ е  в а  р и к  с а  ј е д  њ а  к а  м у л  т и  б а н д  л и  г а  т о  р о м  ( Е Б Л  
гру  па), док је дру  гу гру  пу чи  ни  ло 25 бо  ле  сни  ка код ко  јих је 
п р и  м е  њ е  н а  с к л е  р о  т е  р а  п и  ј а  в а  р и к  с а  п о  л и  д о  к а  н о  л о м  и л и  а п -
с о  л у т  н и м  а л  к о  х о  л о м  н а  к о н  с м а  њ е  њ а  в е  л и  ч и  н е  в а  р и к  с а  л и -
ги  ра  њем (ЕБЛ и ЕИС гру  па).
Ре зул та ти  Н и  ј е   б и  л о   с т а  т и  с т и ч  к и   з н а ч а ј  н е   р а з  л и  к е   и з  м е  ђ у  
и с  п и  т и  в а  н и х  г р у  п а  б о  л е  с н и  к а  у  п о  гл е  д у  б р о  ј а  се  с и  ј а  д о  и с  к о -
р е  њ и  в а  њ а  в а  р и к  с а ,  р е  ц и  д и  в а  к р  в а  р е  њ а ,  п о  г о р  ш а  њ а  п о р т  н е  
г а  с т р о  п а  т и  ј е  и  м о р  т а  л и  т е  т а  т о  к о м  п е  р и  о  д а  к л и  н и ч  к о г  п р а -
ће  ња од 18,8±18,6 ме  се  ци (ЕБЛ гру  па), од  но  сно 22,2±26,2 
ме се ца  (ЕБЛ  и  ЕИС  гру па).  Ре ци див  ва рик са  је  по твр ђен  код 
21, 7 %  и с  п и  т а  н и  к а  п р  в е ,  о д  н о  с н о  16 %  и с  п и  т а  н и  к а  д р у  г е  г р у -
пе, али раз ли ка ни је би ла ста ти стич ки зна чај на. Не ке од ком-
пли ка ци ја, као што су дис фа ги ја и бол у гру ди ма, би ле су ста-
ти стич ки  зна чај но  че шће  код  бо ле сни ка  ЕБЛ  и  ЕИС  гру пе.
За кљу чак  К о м  б и  н о  в а  н а   м е  т о  д а   л и  г и  р а  њ а   и   д о  д а т  н е   с к л е -
р о  з а  ц и  ј е   з а  о  с т а  л и х   м а  л и х   в а  р и к  с а   ј е д  њ а  к а   н а  к о н   л и  г и  р а -
ња  не ма  пред но сти  у  од но су  на  са мо  ли ги ра ње  ва рик са.
Кључ не  ре чи:  в а  р и к  с и   ј е д  њ а  к а ;   е н  д о  с к о п  с к о   л и  г и  р а  њ е ;  
с к л е  р о  т е  р а  п и  ј а ;   р е  ц и  д и в   в а  р и к  с а
Да ли склеротерапија заосталих малих варикса једњака након 
ендоскопског лигирања има утицаја на смањење рецидива варикса? 
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